U.S., March 27 -- ClinicalTrials.gov registry received information related to the study (NCT06895863) titled 'COpenhagen Magnetic Personalized Accelerated Brain Circuit Therapy for Treatment Resistant Depression' on Jan. 16.
Brief Summary: The CoMPACT trial is a randomized double-blinded sham-controlled study aimed at testing a novel accelerated and personalized transcranial Magnetic Stimulation (TMS) treatment for patients with Treatment Resistant Depression (TRD).
CoMPACT consists of 25 sessions of intermittent theta-burst transcranial stimulation (iTBS) consisting of high inter-pulse frequency administered five times daily over five consecutive days.
The trial will include 78 patients with TRD who will be randomly assigned to one of t...